AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
_6ff029a61766633234293.png?format=webp&width=1186&height=250)
Centene Corp (CNC) Falls 3.42% Amidst Analyst Estimates
ByAinvest
Friday, Jul 18, 2025 1:47 pm ET1min read
Centene Corp (CNC) shares fell 3.42% on Jul 17, reaching an intraday low of $29.23. The stock is down 63.56% from its 52-week high and 0.48% above its 52-week low. Analysts forecast an average target price of $58.22, implying an upside of 98.23%. The estimated GF Value is $96.54, suggesting a 228.7% upside from the current price.
Title: Centene Corporation (CNC) Shares Plummet Amidst Market ChallengesCentene Corporation (CNC) shares experienced a significant downturn on July 17, falling by 3.42% to reach an intraday low of $29.23. The stock is currently down 63.56% from its 52-week high and is trading just 0.48% above its 52-week low of $32.26 [1]. Analysts forecast an average target price of $58.22, indicating a potential upside of 98.23%. The estimated GF Value is $96.54, suggesting a substantial 228.7% upside from the current price.
The decline in Centene's stock price can be attributed to several factors. The company withdrew its 2025 financial guidance due to challenges in its Marketplace business and Medicaid sector. This withdrawal is estimated to reduce expected risk adjustment revenue transfers by $1.8 billion, impacting earnings per share by $2.75 [1]. Analysts from Wolfe Research suggest that similar trends across Centene’s remaining markets could increase the total impact to approximately $2.5 billion or $3.80 per share.
Despite the challenges, Truist Securities maintained its Buy rating on Centene, while Cantor Fitzgerald lowered its price target to $65, reflecting reduced earnings estimates. Meanwhile, CVS Health (NYSE:CVS) continues to hold a Buy rating from TD Cowen, which sees limited exposure to the risks currently affecting Centene. TD Cowen’s analysis suggests that CVS’s diversified revenue mix could mitigate potential impacts on its earnings [1].
Additionally, Centene's stock has been trading in oversold territory, as indicated by its Relative Strength Index (RSI). The company's management has been actively buying back shares, which may provide some support for the stock price in the short term [1].
References:
[1] https://ng.investing.com/news/company-news/centene-corp-stock-hits-52week-low-at-3226-93CH-1999680
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet